TRASTUZUMAB BOTIDOTIN
UNII 6HUZ008AZX

Substance Identification & Data

This profile provides standardized clinical and technical data for Trastuzumab Botidotin, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 6HUZ008AZX.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2699055-12-2 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

6HUZ008AZX

CAS Registry Number

2699055-12-2

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

TRASTUZUMAB BOTIDOTIN

Official standardized name for this substance within the FDA UNII nomenclature system.

NCI Thesaurus

C156480

National Cancer Institute reference terminology for clinical and research data.

INN ID

12435

Sequential identifier assigned via the WHO International Nonproprietary Name program.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Trastuzumab Botidotin. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

TRASTUZUMAB BOTIDOTIN

Common Names & Synonyms

A 166 [WHO-DD]

ANTI-HER2 ANTIBODY-DRUG CONJUGATE A166

IMMUNOGLOBULIN G1, ANTI-(HUMAN EPIDERMAL GROWTH FACTOR RECEPTOR HER2) (HUMAN-MUS MUSCULUS MONOCLONAL RHUMAB HER2 .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN-MUS MUSCULUS MONOCLONAL RHUMAB HER2 .KAPPA.-CHAIN, DIMER, 188'',188'''-DIAMIDE WITH N-(4-(4-CARBOXY-1-PIPERIDINYL)-1,4-DIOXOBUTYL)-L-VALYL-N5-(AMINOCARBONYL)-N-(4-((2S)-3-AZIDO-2-(((2R)-3-((2S)-1-((3R,4S,5S)-4-((N,N-DIMETHYL-L-VALYL-L-VALYL)METHYLAMINO)-3-METHOXY-5-METHYL-1-OXOHEPTYL)-2-PYRROLIDINYL)-3-METHOXY-2-METHYL-1-OXOPROPYL)AMINO)PROPYL)PHENYL)-L-ORNITHINAMIDE

TRASTUZUMAB BOTIDOTIN [INN]